Charles Schwab’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19M | Sell |
2,477,941
-23,725
| -0.9% | -$162K | ﹤0.01% | 1772 |
|
|
2025
Q4 | $4.95M | Buy |
2,501,666
+202,206
| +9% | +$458K | ﹤0.01% | 2460 |
|
|
2025
Q3 | $5.66M | Buy |
2,299,460
+523,894
| +30% | +$1.35M | ﹤0.01% | 2385 |
|
|
2025
Q2 | $4.69M | Buy |
1,775,566
+473,483
| +36% | +$1.27M | ﹤0.01% | 2357 |
|
|
2025
Q1 | $3.92M | Buy |
1,302,083
+25,410
| +2% | +$77K | ﹤0.01% | 2377 |
|
|
2024
Q4 | $3.27M | Buy |
1,276,673
+10,692
| +0.8% | +$44.5K | ﹤0.01% | 2524 |
|
|
2024
Q3 | $4.71M | Buy |
1,265,981
+29,665
| +2% | +$137K | ﹤0.01% | 2402 |
|
|
2024
Q2 | $7.81M | Buy |
1,236,316
+65,104
| +6% | +$429K | ﹤0.01% | 2154 |
|
|
2024
Q1 | $6.29M | Buy |
1,171,212
+28,287
| +2% | +$128K | ﹤0.01% | 2205 |
|
|
2023
Q4 | $5.74M | Buy |
1,142,925
+92,991
| +9% | +$292K | ﹤0.01% | 2249 |
|
|
2023
Q3 | $1.77M | Buy |
1,049,934
+71,387
| +7% | +$143K | ﹤0.01% | 2635 |
|
|
2023
Q2 | $2.72M | Buy |
978,547
+262,912
| +37% | +$743K | ﹤0.01% | 2457 |
|
|
2023
Q1 | $1.3M | Sell |
715,635
-7,884
| -1% | -$24.5K | ﹤0.01% | 2648 |
|
|
2022
Q4 | $3.67M | Buy |
723,519
+11,301
| +2% | +$62.1K | ﹤0.01% | 2366 |
|
|
2022
Q3 | $3.54M | Buy |
712,218
+237,948
| +50% | +$1.08M | ﹤0.01% | 2395 |
|
|
2022
Q2 | $1.76M | Sell |
474,270
-18,789
| -4% | -$75.5K | ﹤0.01% | 2607 |
|
|
2022
Q1 | $2.77M | Buy |
493,059
+16,672
| +3% | +$102K | ﹤0.01% | 2539 |
|
|
2021
Q4 | $2.9M | Buy |
476,387
+18,182
| +4% | +$137K | ﹤0.01% | 2575 |
|
|
2021
Q3 | $4.46M | Sell |
458,205
-33,654
| -7% | -$370K | ﹤0.01% | 2427 |
|
|
2021
Q2 | $7.02M | Buy |
491,859
+234,631
| +91% | +$3.88M | ﹤0.01% | 2187 |
|
|
2021
Q1 | $6.11M | Buy |
257,228
+3,780
| +1% | +$98K | ﹤0.01% | 2196 |
|
|
2020
Q4 | $3.38M | Sell |
253,448
-1,777
| -0.7% | -$17.1K | ﹤0.01% | 2406 |
|
|
2020
Q3 | $1.77M | Buy |
255,225
+49,222
| +24% | +$491K | ﹤0.01% | 2533 |
|
|
2020
Q2 | $2.53M | Buy |
206,003
+37,948
| +23% | +$214K | ﹤0.01% | 2337 |
|
|
2020
Q1 | $484K | Buy |
168,055
+3,352
| +2% | +$16.8K | ﹤0.01% | 2725 |
|
|
2019
Q4 | $625K | Buy |
164,703
+37,660
| +30% | +$64.1K | ﹤0.01% | 2738 |
|
|
2019
Q3 | $155K | Buy |
127,043
+46,514
| +58% | +$57.7K | ﹤0.01% | 3069 |
|
|
2019
Q2 | $83K | Sell |
80,529
-55,934
| -41% | -$64.5K | ﹤0.01% | 3132 |
|
|
2019
Q1 | $216K | Buy |
136,463
+2,686
| +2% | +$3.37K | ﹤0.01% | 3008 |
|
|
2018
Q4 | $156K | Sell |
133,777
-2,584
| -2% | -$5.91K | ﹤0.01% | 3047 |
|
|
2018
Q3 | $505K | Buy |
136,361
+14,653
| +12% | +$46.3K | ﹤0.01% | 2836 |
|
|
2018
Q2 | $373K | Buy |
121,708
+3,741
| +3% | +$13.9K | ﹤0.01% | 2891 |
|
|
2018
Q1 | $459K | Buy |
117,967
+3,393
| +3% | +$14.9K | ﹤0.01% | 2757 |
|
|
2017
Q4 | $515K | Buy |
114,574
+4,524
| +4% | +$21.4K | ﹤0.01% | 2716 |
|
|
2017
Q3 | $604K | Buy |
110,050
+4,891
| +5% | +$30.1K | ﹤0.01% | 2664 |
|
|
2017
Q2 | $799K | Buy |
105,159
+53,134
| +102% | +$230K | ﹤0.01% | 2536 |
|
|
2017
Q1 | $185K | Sell |
52,025
-24,492
| -32% | -$121K | ﹤0.01% | 2939 |
|
|
2016
Q4 | $438K | Buy |
76,517
+4,928
| +7% | +$32.9K | ﹤0.01% | 2701 |
|
|
2016
Q3 | $557K | Buy |
71,589
+31,836
| +80% | +$238K | ﹤0.01% | 2577 |
|
|
2016
Q2 | $248K | Buy |
39,753
+19,878
| +100% | +$154K | ﹤0.01% | 2860 |
|
|
2016
Q1 | $164K | Buy |
19,875
+459
| +2% | +$4.33K | ﹤0.01% | 2939 |
|
|
2015
Q4 | $337K | Buy |
19,416
+8,985
| +86% | +$133K | ﹤0.01% | 2821 |
|
|
2015
Q3 | $120K | Buy |
+10,431
| New | +$228K | ﹤0.01% | 3016 |
|
Other funds holding IBRX
VPM
VCM
HF
WP